Evidence mapPaperPMID 40995309Full record

ReviewTaiwan journal of ophthalmology

Advancing optical coherence tomography angiography to the clinic.

Tristan T Hormel, Yali Jia

Abstract readReview
In one paragraph

Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tristan T HormelCasey Eye Institute, Oregon Health and Science University, Portland, OR, USA.
Yali JiaCasey Eye Institute, Oregon Health and Science University, Portland, OR, USA.

Funding

Proteomics CoreP30EY010572 · OREGON HEALTH & SCIENCE UNIVERSITY · 1995 to 2025
$4.4M
Advancing visible-light OCT in oxygen-induced retinopathyR01EY036429 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$692k
OCT Angiography for Age-related Macular DegenerationR01EY024544 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$680k
OCTA Precursors of Vision-Threatening Complications of Diabetic RetinopathyR01EY035410 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$627k
Translational Vision Science Research at Oregon Health & Science UniversityT32EY023211 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$178k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY024544NEI NIH HHS R01 EY027833NEI NIH HHS R01 EY035410NEI NIH HHS R01 EY036429NEI NIH HHS R43 EY036781NEI NIH HHS T32 EY023211NIDDK NIH HHS DP3 DK104397
6 · The paper itself

Abstract

Optical coherence tomography (OCT) angiography (OCTA) is a new clinical technology that advances the capabilities of OCT imaging by adding the ability to readily visualize vascular anatomy down to the capillary scale. With this level of detail, OCTA can be used to identify many important vascular pathologies such as capillary dropout, microaneurysms, or neovascularization. Because it offers high-resolution, high-contrast imaging of these and similar features, OCTA is useful not just for visualization but also for quantification. Quantification is a powerful feature that enables the potential for diagnostics, staging, evaluation of treatment response, and patient monitoring in a more rigorous way than simple observation. In this review, we will examine several OCTA measurements with either demonstrated clinical utility or clinical potential through the lens of three prevalent blinding diseases: diabetic retinopathy, age-related macular degeneration, and glaucoma. We will discuss the merits of these various measurements and care that should be taken in their interpretation and analyze their role in patient management.

Indexed as

Biomarkersoptical coherence tomography angiographyretinal disease

Identifiers

PMID40995309
PMCPMC12456915

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.